Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Deficiency in the omega-3 lysolipid transporter Mfsd2a leads to aberrant oligodendrocyte lineage development and hypomyelination
Vetrivel Sengottuvel, … , Federico Torta, David L. Silver
Vetrivel Sengottuvel, … , Federico Torta, David L. Silver
Published April 27, 2023
Citation Information: J Clin Invest. 2023;133(12):e164118. https://doi.org/10.1172/JCI164118.
View: Text | PDF
Research Article Metabolism Neuroscience

Deficiency in the omega-3 lysolipid transporter Mfsd2a leads to aberrant oligodendrocyte lineage development and hypomyelination

  • Text
  • PDF
Abstract

Patients with autosomal recessive microcephaly 15 caused by deficiency in the sodium-dependent lysophosphatidylcholine (LPC) transporter major facilitator superfamily domain–containing 2a (Mfsd2a) present with both microcephaly and hypomyelination, suggesting an important role for LPC uptake by oligodendrocytes in the process of myelination. Here we demonstrate that Mfsd2a is specifically expressed in oligodendrocyte precursor cells (OPCs) and is critical for oligodendrocyte development. Single-cell sequencing of the oligodendrocyte lineage revealed that OPCs from OPC-specific Mfsd2a-KO mice (2aOKO mice) underwent precocious differentiation into immature oligodendrocytes and impaired maturation into myelinating oligodendrocytes, correlating with postnatal brain hypomyelination. 2aOKO mice did not exhibit microcephaly, a finding consistent with the notion that microcephaly is the consequence of an absence of LPC uptake at the blood-brain barrier rather than a deficiency in OPCs. Lipidomic analysis showed that OPCs and iOLs from 2aOKO mice had significantly decreased levels of phospholipids containing omega-3 fatty acids, with a corresponding increase in unsaturated fatty acids, the latter being products of de novo synthesis governed by Srebp-1. RNA-Seq indicated activation of the Srebp-1 pathway and defective expression of regulators of oligodendrocyte development. Taken together, these findings indicate that the transport of LPCs by Mfsd2a in OPCs is important for maintaining OPC state to regulate postnatal brain myelination.

Authors

Vetrivel Sengottuvel, Monalisa Hota, Jeongah Oh, Dwight L. Galam, Bernice H. Wong, Markus R. Wenk, Sujoy Ghosh, Federico Torta, David L. Silver

×

Figure 1

Loss of Mfsd2a in OPCs causes hypomyelination.

Options: View larger image (or click on image) Download as PowerPoint
Loss of Mfsd2a in OPCs causes hypomyelination.
(A) P8 brain weights of 2...
(A) P8 brain weights of 2afl/fl and 2aOKO mouse pups indicate no microcephaly due to Mfsd2a knockout in OPCs. Data are presented as mean ± SEM; n = 7 per genotype. (B–G) Representative images and quantification of coronal sections of the corpus callosum from P8 brain immunostained with the myelin marker proteins MBP (B and E), MAG (C and F), and CNPase (D and G) indicate hypomyelination in 2aOKO compared with 2afl/fl control mice. Data are presented as mean ± SEM; n = 3–5 per genotype. Scale bars: 100 μm. ***P < 0.0001, **P < 0.001 by 2-tailed Student’s t test (unpaired). (H) Representative TEM images of the corpus callosum of P67 brains from 2afl/fl and 2aOKO mice. Scale bars: 500 nm. (I) Graphical representation of the g-ratio of individual fibers in relation to axon diameter presented as scatter plots for 2afl/fl and 2aOKO mice. (J) Histogram of g-ratio comparison between 2afl/fl and 2aOKO mice. Data are presented as mean ± SEM; n = 3 per genotype. *P < 0.05 by 2-tailed Student’s t test (unpaired).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts